We found that FAM46A expression was significantly correlated with activated gene signatures of TGF-β/Smad pathways (Figure 5(b)), suggesting that TGF-β/Smad pathways might contribute to FAM46A mediated chemo-resistance effect on ovarian cancer. The gene discussed is TGFB1; the disease is ovarian cancer.